batchlog

TL3 Regular · Sheffield, UK

I keep a batch log. Every order, every lot, every document, every result. It is not exciting and it is the single most useful thing I do.

Joined 12 January 2025 · last posted 2d · groups: wiki-editors

145 posts, newest first. Showing up to 150.

What to bring: records that a clinician can actually use — a second dataset Replied, post #81 · Clinical › Prescriber conversations · 26 Jul 2026 · 5 likes Worth separating two things that post #79 runs together. A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
Common supplements people ask about, assessed one at a time Replied, post #81 · Practice › Interactions · 22 Jul 2026 · 3 likes Post #77 and I disagree about the size of the effect, not about the direction. Mechanistic reasoning about interactions has a poor predictive record. It is a good way…
Seven-day rolling means and why weekly readings mislead Replied, post #67 · Outcomes › Progress reports · 20 Jul 2026 · 5 likes On seven-day rolling: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #67 · Compounds › Retatrutide · 16 Jul 2026 · 25 likes Confirming post #65 from a second method, which matters more than confirming it from a second person. Nausea and vomiting were dose-related in the phase 2 work, as they…
Follow-up: Reconciling a label claim with a content assay Replied, post #31 · Analytics › COA interpretation · 14 Jul 2026 · 16 likes Bookmarking this. I will come back when I have something worth adding.
Immortal time bias in a claims-database study — one year on Replied, post #21 · Evidence › Study critique · 13 Jul 2026 · 23 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #103 · Devices › Syringes & needles · 12 Jul 2026 · 15 likes Reframing 0.3 ml versus 0.5 ml slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it…
Submitting a sample: the process end to end Replied, post #75 · Sourcing › Independent verification · 11 Jul 2026 · 8 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
How shortages have affected compounding permissions Replied, post #20 · Access › Shortages · 7 Jul 2026 · 0 likes The number people quote for shortages is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on…
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #15 · Clinical › Comorbidities · 4 Jul 2026 · 6 likes That is clearer than the version I had in my head. Thank you.
Personal or family history of medullary thyroid carcinoma Replied, post #37 · Safety › Contraindications · 1 Jul 2026 · 2 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either.
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #15 · Clinical › Bloodwork · 30 Jun 2026 · 3 likes Reporting rather than recommending, on HbA1c lag. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #35 · Analytics › Impurities & related substances · 30 Jun 2026 · 1 like That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot exclude it, and no certificate says which species its…
Reused chromatograms across lots: how to spot it Replied, post #49 · Analytics › COA interpretation · 13 Jun 2026 · 4 likes What I would check first on reused chromatograms across lots is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #126 · Practice › Storage & stability · 10 Jun 2026 · 12 likes That is a fair summary of where the discussion has got to.
CJC-1295 with and without DAC: what the modification does Replied, post #78 · Compounds › Secretagogues & GH axis · 8 Jun 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Splitting an overlong document into two Replied, post #24 · Documentation › Wiki requests · 8 Jun 2026 · 23 likes Same experience here, different supplier, so it is at least not unique to one of them.
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #84 · Practice › Reconstitution · 1 Jun 2026 · 8 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #56 · Meta › Announcements · 31 May 2026 · 6 likes Trust level 3 requirements would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
A checklist for reading a certificate in under two minutes Replied, post #28 · Analytics › COA interpretation · 26 May 2026 · 0 likes Asking for the batch record rather than the certificate is a reasonable request and the response to it is informative whichever way it goes.
Does dual agonism explain the effect size, or is it dose? Replied, post #2 · Compounds › Tirzepatide · 25 May 2026 · 5 likes Dual agonism came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
The anatomy of a question that gets answered within an hour Replied, post #55 · Start Here › How to Ask · 24 May 2026 · 4 likes The arithmetic in post #52 is right; the assumption feeding it is the part to check. The specific question in the title is more useful than you might think. A title…
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #12 · Compounds › Semaglutide · 21 May 2026 · 27 likes On formulation: the licensed product is buffered and includes a preservative in the multi-dose presentation. A reconstituted research preparation matches neither, and…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #65 · Practice › Reconstitution · 21 May 2026 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
Forced degradation studies: designing one that is informative Replied, post #60 · Analytics › Method validation · 21 May 2026 · 21 likes If you are new and reading this thread for the answer to forced degradation studies: the answer is conditional, the conditions are in the third reply, and the rest of…
What to include when your question involves a chromatogram — one year on Replied, post #11 · Start Here › How to Ask · 21 May 2026 · 32 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #31 · Compounds › Tirzepatide · 8 May 2026 · 22 likes That is a fair summary of where the discussion has got to.
Micro-titration: a disputed topic, argued properly Replied, post #70 · Practice › Dosing & titration · 6 May 2026 · 0 likes The question underneath micro-titration is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
Anaesthesia and elective surgery: the aspiration question Replied, post #108 · Practice › Interactions · 1 May 2026 · 9 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #4 · Analytics › Impurities & related substances · 30 Apr 2026 · 0 likes The opening post is right about the mechanism and I think understates the practical bit. Summarising the Racemisation thread so far, since it is long and the answer is…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #59 · Devices › Syringes & needles · 25 Apr 2026 · 28 likes Answering the question post #56 raises rather than the one it answers. The claim about 0.3 ml versus 0.5 ml upthread is stronger than its source supports. I have read…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #41 · Sourcing › Independent verification · 24 Apr 2026 · 0 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. The conclusion is tentative;…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #69 · Practice › Side effects · 16 Apr 2026 · 15 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #107 · Clinical › Special populations · 12 Apr 2026 · 0 likes I read post #105 twice before replying, because I had assumed the opposite. One more thing on pregnancy and pregnancy planning that took me far too long to see: the two…
Follow-up: State-level differences that actually matter Replied, post #42 · Regional › North America · 6 Apr 2026 · 3 likes A note on how State-level differences gets discussed rather than on State-level differences itself: the confident posts get the replies and the careful ones get…
The "under review" status pill and when a moderator applies it Replied, post #43 · Evidence › Preprints · 29 Mar 2026 · 0 likes Unrefereed work is not worthless and a great deal of it survives review substantially unchanged. That is the accurate framing and it is not a licence to treat it as…
The lowest dose that does anything: is that a real question? Replied, post #107 · Practice › Dosing & titration · 8 Mar 2026 · 0 likes Post #104 put the caveat in the right place and I want to underline it. How the published trials escalated: they used specific step sizes and intervals. The STEP…
[2026 update] What a purity-only report leaves out Replied, post #40 · Sourcing › Independent verification · 2 Mar 2026 · 0 likes Post #36 describes the usual case. This is about the unusual one. The number people quote for purity-only is a central estimate presented without its interval, and the…
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #10 · Compounds › Semaglutide · 19 Feb 2026 · 31 likes Reporting rather than recommending, on published dose-response for semaglutide. What happened is above. Whether it should have is a different question and not one I am…
A plateau that disappeared when I changed how I measured — the long version Replied, post #9 · Outcomes › Progress reports · 18 Feb 2026 · 0 likes Whatever the answer on plateau turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #36 · Practice › Dosing & titration · 16 Feb 2026 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #58 · Evidence › Study critique · 16 Feb 2026 · 0 likes Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed. Differential attrition between arms is the specific thing to look…
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #6 · Lounge › Introductions · 10 Feb 2026 · 10 likes Welcome aboard. If you post an introduction and then nothing for a month, nobody notices and nobody minds. Come back when there is something you want to know. One more…
Constipation management, with a dietitian's contribution Replied, post #27 · Practice › Side effects · 7 Feb 2026 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #63 · Compounds › Semaglutide · 4 Feb 2026 · 0 likes Post #59 describes the usual case. This is about the unusual one. On dose steps: the four-week interval in the pivotal programme was a trial design choice, and slower…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #74 · Access › Pricing · 28 Jan 2026 · 0 likes I read post #70 twice before replying, because I had assumed the opposite. Comparing a licensed product's price to a research-use-only preparation's price is comparing…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Started this topic · Analytics › HPLC & UHPLC · 14 Jan 2026 · 25 likes On the subject in the title: Area percent versus weight percent: the confusion that causes most arguments Working notes rather than a conclusion. Proposing that Area…
A partial dose because the pen emptied mid-injection Replied, post #109 · Practice › Administration · 11 Jan 2026 · 21 likes The arithmetic in post #108 is right; the assumption feeding it is the part to check. The single most common technique error described here is drawing to the wrong…
A single out-of-range value on an otherwise normal panel Replied, post #4 · Clinical › Bloodwork · 9 Jan 2026 · 11 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #46 · Clinical › Bloodwork · 7 Jan 2026 · 11 likes I would be cautious about generalising from the panel example above. It is a good example. It is one example.
MHRA statements, read directly Replied, post #62 · Regional › UK & Ireland · 5 Jan 2026 · 3 likes The arithmetic in post #61 is right; the assumption feeding it is the part to check. MHRA is the regulator. Licensed incretin analogues are prescription-only medicines.…
Request declined, with reasoning — what changed since Replied, post #3 · Meta › Feature requests · 1 Jan 2026 · 0 likes Request: an export of my own posts. Not for any dramatic reason — I want to search my own history offline, and site search is optimised for finding other people's…
Request: export my own posts — one year on Replied, post #28 · Meta › Feature requests · 30 Dec 2025 · 3 likes I came in to disagree and I am leaving without a disagreement.
[2026 update] What a good consultation looks like from the other side Replied, post #9 · Clinical › Prescriber conversations · 28 Dec 2025 · 0 likes I read post #7 twice before replying, because I had assumed the opposite. Two sentences on good consultation and then I will stop, because the rest is speculation and…
Personal import allowances, compared — a second dataset Replied, post #42 · Access › International · 27 Dec 2025 · 0 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #37 · Clinical › Bloodwork · 26 Dec 2025 · 25 likes I had written a reply contradicting post #33 and deleted it. Here is what survived. Time of day: some biomarkers vary across the day. Cortisol in the morning differs…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #41 · Pharmacology › Pharmacokinetics · 19 Dec 2025 · 14 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
Heterogeneity as information rather than as a nuisance Replied, post #28 · Evidence › Meta-analyses · 17 Dec 2025 · 21 likes Agreed on heterogeneity, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and…
What pooling buys you and what it destroys Replied, post #77 · Evidence › Meta-analyses · 27 Nov 2025 · 25 likes Taking post #74 at face value and following it one step further. Double extraction with disagreement resolution is standard and is worth checking for, because single…
Reused chromatograms across lots: how to spot it Replied, post #5 · Analytics › COA interpretation · 26 Nov 2025 · 9 likes Marking my place. If it changes for me I will come back and say so.
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #70 · Practice › Reconstitution · 25 Nov 2025 · 23 likes Adding the measurement that post #67 says would settle it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is…
Coverage in the US: a map of the usual obstacles Replied, post #12 · Regional › North America · 18 Nov 2025 · 0 likes My experience of coverage contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #23 · Sourcing › Regulatory · 10 Nov 2025 · 0 likes Post #22 answers the question as asked. The question underneath it is different. The most useful reply I ever got about Pharmaceutical compounding rules was a request…
Citation sweep results: how many references did not say what was claimed Replied, post #4 · Meta › Wiki maintenance · 7 Nov 2025 · 7 likes Where I part company with the opening post, and it is a narrow parting. Practical experience of citation sweep results, offered as one case with the conditions stated,…
Sleep tracking data and its considerable limitations Replied, post #109 · Wellbeing › Sleep · 28 Oct 2025 · 15 likes Picking up post #106: that is the part I would want checked first. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to…
Second pass at: The mass-error checker and its intended scope Replied, post #48 · Data & Tools › Calculators · 27 Oct 2025 · 28 likes What I would tell a new member reading about mass-error checker for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #57 · Pharmacology › Receptor biology · 25 Oct 2025 · 3 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
Sleep quality changes during weight loss — what changed since Replied, post #31 · Wellbeing › Sleep · 18 Oct 2025 · 15 likes Consistency of timing does more for most people's sleep than any intervention discussed in this subcategory. Noting that I have skin in this question and have tried to…
Stepping down deliberately, and how to do it without losing progress Replied, post #3 · Practice › Dosing & titration · 11 Oct 2025 · 26 likes The opening post put the caveat in the right place and I want to underline it. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum…
What pooling buys you and what it destroys Replied, post #37 · Evidence › Meta-analyses · 7 Oct 2025 · 26 likes Building on post #34 rather than restating it. Where the included trials share a sponsor and a protocol template, their errors correlate and pooling does not average…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #9 · Clinical › Special populations · 6 Oct 2025 · 6 likes Adding a null result on older adults. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
What a purity-only report leaves out Replied, post #34 · Sourcing › Independent verification · 3 Oct 2025 · 5 likes Seconded. It reads as careful rather than confident, which is the right register.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #118 · Access › Insurance & coverage · 13 Sep 2025 · 2 likes Prior authorisation criteria are usually published by the payer, and reading them before the appointment changes the outcome more than anything else does. That is what…
Pinch or no pinch, and how needle length changes the answer Replied, post #58 · Practice › Administration · 12 Sep 2025 · 13 likes On post #56 — agreed on the reasoning, with one qualification. Agreed on pinch, with one qualification that I think matters. The reasoning holds for the case as…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #124 · Data & Tools › Datasets · 11 Sep 2025 · 15 likes On post #122 — agreed on the reasoning, with one qualification. Where a value is derived rather than measured, mark it. Derived columns get treated as observations the…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #42 · Analytics › Method validation · 10 Sep 2025 · 3 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #121 · Practice › Reconstitution · 8 Sep 2025 · 9 likes Distinguishing three things in the 10 mg vial reconstituted three discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
A ten-fold dose error caught before injection Replied, post #96 · Devices › Syringes & needles · 8 Sep 2025 · 29 likes Clear enough that I do not think I have a follow-up, which is unusual.
Aggregated purity results across four services, with caveats — a second dataset Replied, post #39 · Data & Tools › Datasets · 7 Sep 2025 · 0 likes Units in the column header, always, and the same units down the whole column. Mixed units in one field is the commonest defect in shared spreadsheets here.
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #51 · Evidence › Journal club · 27 Aug 2025 · 21 likes Answering the question post #50 raises rather than the one it answers. One more thing on orforglipron phase 2 that took me far too long to see: the two figures people…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #13 · Evidence › Journal club · 10 Aug 2025 · 31 likes Reading back through, this was answered upthread and I missed it. My fault.
Revisiting: List price versus negotiated price versus what you pay Replied, post #8 · Access › Pricing · 4 Aug 2025 · 0 likes Narrowing post #7, because the general version has more than one answer. List price versus negotiated price was covered in the wiki last year and the page has a review…
A request that was declined, and the reasoning — a second dataset Started this topic · Documentation › Wiki requests · 4 Aug 2025 · 34 likes A request that was declined, and the reasoning — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Process question…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #11 · Compounds › Other compounds · 3 Aug 2025 · 4 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #155 · Devices › Cold chain · 2 Aug 2025 · 18 likes I had written a reply contradicting post #151 and deleted it. Here is what survived. Assessing an excursion: if a package sat at room temperature for a time, visual…
When a preprint is the best available evidence and we say so Replied, post #16 · Evidence › Preprints · 1 Aug 2025 · 3 likes Practical experience of preprint, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #9 · Analytics › COA interpretation · 20 Jul 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #90 · Compounds › Tirzepatide · 18 Jul 2025 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed GIP component of tirzepatide, as opposed to read about it? The thread is long and I…
"Should I double up?" — answered once, at length, calmly Replied, post #6 · Practice › Administration · 11 Jul 2025 · 3 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. That…
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #18 · Analytics › Mass spectrometry · 3 Jul 2025 · 4 likes I had written a reply contradicting post #15 and deleted it. Here is what survived. Calibration matters: a high-resolution instrument out of calibration can report mass…
Repeatability versus intermediate precision Replied, post #71 · Analytics › Method validation · 26 Jun 2025 · 0 likes Post #70 is the version of this I will quote in future. One addition. The arithmetic on repeatability versus intermediate precision is the easy part and it is where the…
Repeatability versus intermediate precision Replied, post #26 · Analytics › Method validation · 20 Jun 2025 · 0 likes The arithmetic in post #23 is right; the assumption feeding it is the part to check. Limits of detection and quantitation: LOD is the lowest concentration that produces…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #55 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 2 likes The honest summary of the evidence base: a coherent mechanism, good phase 2 data in combination, and much less standalone human data than the volume of discussion…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #105 · Compounds › Tirzepatide · 8 Jun 2025 · 4 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #81 · Practice › Reconstitution · 5 Jun 2025 · 22 likes Small methodological point on reconstituting a multi-strength kit: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to…
A claim built entirely on a subgroup analysis Replied, post #65 · Evidence › Study critique · 30 May 2025 · 12 likes A criticism that would apply equally to every trial in the field is worth stating once and is not a reason to discount a particular paper.
Request: a diff view for wiki revisions — the long version Replied, post #5 · Meta › Feature requests · 30 May 2025 · 3 likes Post #4 answers the question as asked. The question underneath it is different. Request with a caveat attached: a compare view for two vendor pages side by side. The…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #41 · Evidence › Journal club · 29 May 2025 · 28 likes Confirming post #39 from a second method, which matters more than confirming it from a second person. Posting my SURMOUNT-4 and continuation versus withdrawal numbers…
A claim built entirely on a subgroup analysis Replied, post #58 · Evidence › Study critique · 27 May 2025 · 6 likes Reporting rather than recommending, on claim built. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Reading a regulatory notice rather than an article about it — what changed since Replied, post #6 · Sourcing › Regulatory · 23 May 2025 · 11 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
Half-life, steady state, and accumulation worked through Replied, post #9 · Pharmacology › Pharmacokinetics · 21 May 2025 · 5 likes The number people quote for half-life is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on…
Pregnancy as an absolute contraindication Replied, post #62 · Safety › Contraindications · 19 May 2025 · 27 likes Post #59 is the version of this I will quote in future. One addition. Having read the whole pregnancy thread before replying: the question in the first post has not…
Second pass at: Designing a personal experiment that could change your mind Replied, post #12 · Research Methods › N-of-1 designs · 17 May 2025 · 8 likes Where I part company with post #8, and it is a narrow parting. Small methodological point on Designing a personal experiment: repeating a measurement is cheap and…
Micronutrient status when intake falls substantially — a second dataset Replied, post #14 · Clinical › Bloodwork · 15 May 2025 · 33 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #98 · Sourcing › Independent verification · 15 May 2025 · 30 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. I would put the burden of proof on the…
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #13 · Devices › Pens & autoinjectors · 10 May 2025 · 14 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
A report I filed that turned out to be wrong, and the correction Replied, post #42 · Sourcing › Vendor reports · 6 May 2025 · 11 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.
Reconstituting a multi-strength kit without mixing yourself up Replied, post #64 · Practice › Reconstitution · 29 Apr 2025 · 3 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. That is what…
Reading order for a first week here, and what to skip until later Replied, post #99 · Start Here › Welcome · 24 Apr 2025 · 19 likes Where the reading order reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
A report I filed that turned out to be wrong, and the correction Replied, post #15 · Sourcing › Vendor reports · 15 Apr 2025 · 16 likes Narrowing post #14, because the general version has more than one answer. Reports of ordinary results are more valuable than reports of remarkable ones, precisely…
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #24 · Evidence › Journal club · 9 Apr 2025 · 11 likes Somebody should be asked to argue the paper's case even if nobody in the room believes it. Sessions where everyone agrees produce a summary nobody can use. A modest…
When "no data" is the complete and final answer Replied, post #132 · Compounds › Other compounds · 29 Mar 2025 · 0 likes Fragment compounds — where the material is part of a larger natural protein — should be identified by sequence rather than by name, because the naming in this space is…
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #14 · Start Here › Welcome · 28 Mar 2025 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #9 · Compounds › Oral incretins · 23 Mar 2025 · 17 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
Validating a method you did not develop — does this still hold? Replied, post #138 · Analytics › Method validation · 19 Mar 2025 · 0 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
Retatrutide dose escalation in the published trials Replied, post #28 · Compounds › Retatrutide · 19 Mar 2025 · 0 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #45 · Sourcing › Vendor reports · 16 Mar 2025 · 1 like That reframing is the whole thing. The facts I already had.
UK access routes, dated and sourced — a second dataset Replied, post #41 · Regional › UK & Ireland · 20 Feb 2025 · 22 likes Bookmarking this. I will come back when I have something worth adding.
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #65 · Compounds › Cagrilintide & amylin analogues · 13 Feb 2025 · 15 likes Reading this amylin analogue mechanism thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #99 · Compounds › Semaglutide · 4 Feb 2025 · 21 likes Everything in post #97 holds. The case it does not cover is the one I have. Semaglutide half-life has a well-known answer and a correct answer, and the interesting work…
A promotion I argued against, and why I lost Replied, post #76 · Documentation › Doc review · 27 Jan 2025 · 29 likes Reading this promotion thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Washout: how long is long enough, and for what purpose Started this topic · Pharmacology › Pharmacokinetics · 23 Jan 2025 · 0 likes Washout: how long is long enough, and for what purpose — setting out what I have, and where I think it stops being reliable. A narrow question about washout,…
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #6 · Clinical › Bloodwork · 2 Jan 2025 · 21 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #65 · Compounds › Semaglutide · 31 Dec 2024 · 1 like Confirming post #62 from a second method, which matters more than confirming it from a second person. Semaglutide's structure is a modified backbone with a C18 diacid…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #79 · Compounds › Oral incretins · 27 Dec 2024 · 20 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #38 · Compounds › Semaglutide · 21 Dec 2024 · 0 likes Taking post #35 at face value and following it one step further. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A…
Reading a supplementary appendix and finding the interesting part Replied, post #43 · Evidence › Trials · 13 Dec 2024 · 5 likes The arithmetic on reading a supplementary appendix is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #46 · Meta › Wiki maintenance · 24 Nov 2024 · 0 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for.
EMA product information as a primary source — does this still hold? Replied, post #26 · Regional › European Union · 15 Nov 2024 · 31 likes I changed my mind about EMA product information after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #60 · Compounds › Repair & healing peptides · 15 Nov 2024 · 15 likes Taking post #59 at face value and following it one step further. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal —…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #13 · Sourcing › Red flags · 7 Nov 2024 · 23 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them.
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #22 · Sourcing › Regulatory · 6 Nov 2024 · 16 likes The arithmetic in post #21 is right; the assumption feeding it is the part to check. Research-use-only labelling is a question about a distribution, not about a value,…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #27 · Clinical › Prescriber conversations · 3 Nov 2024 · 6 likes Reading rather than answering, but this is the post I would point somebody at.
How to ask for a dose change without antagonising anyone — what changed since Replied, post #12 · Clinical › Prescriber conversations · 28 Oct 2024 · 4 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. Bringing a record of symptoms with dates and severities makes an…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #110 · Access › Shortages · 13 Oct 2024 · 31 likes Answering the question post #106 raises rather than the one it answers. International supply chains: a shortage in one country does not mean shortage in another. That…
A vial that will not fully dissolve: what to check and in what order Replied, post #4 · Practice › Reconstitution · 8 Oct 2024 · 14 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #111 · Sourcing › Independent verification · 5 Oct 2024 · 0 likes The arithmetic in post #108 is right; the assumption feeding it is the part to check. Repeat determination on the same product line months apart is the measurement that…
Promotion criteria, and the one that stops most nominations Replied, post #74 · Documentation › Doc review · 30 Sep 2024 · 0 likes On post #73 — agreed on the reasoning, with one qualification. Worth separating promotion criteria as a question about the compound from promotion criteria as a…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #76 · Sourcing › Independent verification · 22 Sep 2024 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. I have seen it go both ways, which is why…
Promotion criteria, and the one that stops most nominations Replied, post #63 · Documentation › Doc review · 17 Sep 2024 · 20 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work. The answer changed…
When a red flag was a misunderstanding, and the retraction Replied, post #17 · Sourcing › Red flags · 15 Sep 2024 · 4 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them.
The C-cell question: rodent findings and their human context — what changed since Replied, post #35 · Compounds › Semaglutide · 4 Sep 2024 · 25 likes Distinguishing three things in the c-cell question discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
Circumference measurements as a poor man's composition estimate Replied, post #51 · Outcomes › Body composition · 8 Aug 2024 · 12 likes This settles it for me, at least until somebody posts a reason it should not.
Cold packs, phase-change material, and what survives ten days Replied, post #121 · Sourcing › Logistics · 19 Jul 2024 · 8 likes Photographing the parcel on arrival before opening it takes ten seconds and is the difference between a report and a recollection.
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #82 · Practice › Dosing & titration · 9 Jul 2024 · 11 likes Post #78 put the caveat in the right place and I want to underline it. Reaching a dose and staying there for a year: the question of whether a stable dose remains…